164 related articles for article (PubMed ID: 15313178)
1. Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain.
Xiao X; Feng Y; Chakraborti S; Dimitrov DS
Biochem Biophys Res Commun; 2004 Sep; 322(1):93-9. PubMed ID: 15313178
[TBL] [Abstract][Full Text] [Related]
2. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.
Broer R; Boson B; Spaan W; Cosset FL; Corver J
J Virol; 2006 Feb; 80(3):1302-10. PubMed ID: 16415007
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
4. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
Hwang WC; Lin Y; Santelli E; Sui J; Jaroszewski L; Stec B; Farzan M; Marasco WA; Liddington RC
J Biol Chem; 2006 Nov; 281(45):34610-6. PubMed ID: 16954221
[TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV S glycoprotein: expression and functional characterization.
Xiao X; Chakraborti S; Dimitrov AS; Gramatikoff K; Dimitrov DS
Biochem Biophys Res Commun; 2003 Dec; 312(4):1159-64. PubMed ID: 14651994
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
[TBL] [Abstract][Full Text] [Related]
9. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
[TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV S glycoprotein.
Xiao X; Dimitrov DS
Cell Mol Life Sci; 2004 Oct; 61(19-20):2428-30. PubMed ID: 15526150
[TBL] [Abstract][Full Text] [Related]
11. Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage.
Millet JK; Kien F; Cheung CY; Siu YL; Chan WL; Li H; Leung HL; Jaume M; Bruzzone R; Peiris JS; Altmeyer RM; Nal B
PLoS One; 2012; 7(11):e49566. PubMed ID: 23185364
[TBL] [Abstract][Full Text] [Related]
12. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.
Howard MW; Travanty EA; Jeffers SA; Smith MK; Wennier ST; Thackray LB; Holmes KV
J Virol; 2008 Mar; 82(6):2883-94. PubMed ID: 18199653
[TBL] [Abstract][Full Text] [Related]
13. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.
Tsai JC; Zelus BD; Holmes KV; Weiss SR
J Virol; 2003 Jan; 77(2):841-50. PubMed ID: 12502800
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
[TBL] [Abstract][Full Text] [Related]
16. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.
Lin HX; Feng Y; Wong G; Wang L; Li B; Zhao X; Li Y; Smaill F; Zhang C
J Gen Virol; 2008 Apr; 89(Pt 4):1015-1024. PubMed ID: 18343844
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
[TBL] [Abstract][Full Text] [Related]
18. A trimerizing GxxxG motif is uniquely inserted in the severe acute respiratory syndrome (SARS) coronavirus spike protein transmembrane domain.
Arbely E; Granot Z; Kass I; Orly J; Arkin IT
Biochemistry; 2006 Sep; 45(38):11349-56. PubMed ID: 16981695
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies.
He Y
Adv Exp Med Biol; 2006; 581():539-42. PubMed ID: 17037594
[No Abstract] [Full Text] [Related]
20. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.
Sainz B; Mossel EC; Gallaher WR; Wimley WC; Peters CJ; Wilson RB; Garry RF
Virus Res; 2006 Sep; 120(1-2):146-55. PubMed ID: 16616792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
